Home Food Science and Human Wellness Article
PDF (962 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Review Article | Open Access

A narrative review on inhibitory effects of edible mushrooms against malaria and tuberculosis-the world's deadliest diseases

Ashaimaa Y. Moussaa, Baojun Xub()
Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt
Food Science and Technology Program, BNU-HKBU United International College, Zhuhai 519087, China
Show Author Information

Abstract

The isolated secondary metabolites from 39 edible mushrooms are reported, among which 107 compounds were active, 61 demonstrated antitubercular activities with IC50 range of 0.2–50 µg/mL and 46 manifested antimalarial effects with IC50 range of 0.061–36 µg/mL. While more than 2000 strains of edible mushrooms are identified, this review shows the paucity of research in these rich organisms featuring a vital culinary ingredient worldwide. A thorough search was conducted on basidiomycetes to discuss the chemistry and biology of the isolated compounds, structure activity relationships (SAR) as well as the cytotoxicity profiles of, primarily, the active anti-plasmodial and antitubercular molecules. With a safe cellular profile, lanostane triterpenoids were found to be the only molecules with combined activities against both diseases. SAR correlations reviewed here indicated the significance of 3β- and 7α-hydroxylation in the anti-tuberculosis activity and the terminal unsaturated moiety between C-4 and C-28 in the antimalarial activity in the same terpene skeleton. This review will attract the attention of medicinal chemists, and food scientists to optimize and rationalize the use of mushrooms both as unexploited sources of novel molecules and as nutraceuticals to treat two of the deadliest infectious diseases, malaria, and tuberculosis.

Keywords

AntituberculosisAntiplasmodialMacrofungiMushroomsStructure activity relationship

References

[1]

A.Y. Moussa, H.A. Sobhy, O.A. Eldahshan, et al., Caspicaiene: a new kaurene diterpene with anti-tubercular activity from an Aspergillus endophytic isolate in Gleditsia caspia desf, Nat. Prod. Res. (2020) 1-12. https://doi.org/10.1080/14786419.2020.1824222.

Crossref Google Scholar
[2]

K. Liu, T. Li, A. Vongpradith, et al., Identification and prediction of tuberculosis in Eastern China: analyses from 10-year population-based notification data in Zhejiang province, China, Sci. Rep. 10 (2020) 1-10. https://doi.org/10.1038/s41598-020-64387-5.

Crossref Google Scholar
[3]
M.L. Leonard. Mushrooms as medicinals: a literature review, North American Mycological Association 23 (2014) 25-30. http://www.namyco.org/publications/mcilvainea/v23/mushrooms_as_medicinals.html.
[4]

A. Mwakingwe-Omari, S.A. Healy, J. Lane, et al., Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity, Nature 595 (2021)289-294. https://doi.org/10.1038/s41586-021-03684-z.

Crossref Google Scholar
[5]

M. Maiolini, S. Gause, J. Taylor, et al., The war against tuberculosis: a review of natural compounds and their derivatives, Molecules 25 (2020). https://doi.org/10.3390/molecules25133011.

Crossref Google Scholar
[6]

I.N. Nkumama, F.H.A. Osier, Malaria vaccine roller coaster, Nat. Microbiol. 6 (2021) 1345-1346. https://doi.org/10.1038/s41564-021-00982-0.

Crossref Google Scholar
[7]

J.K. Zjawiony, Antitubercular activity of mushrooms (Basidiomycetes) and their metabolites, Nat. Prod. Commun. 2 (2007) 315-318. https://doi.org/10.1177/1934578X0700200314.

Crossref Google Scholar
[8]

E. Callaway, TB diagnostic test fails to curb cases, Nature 551 (2018) 424.

Crossref Google Scholar
[9]

K. Arpha, C. Phosri, N. Suwannasai, et al., Astraodoric acids A-D: new lanostane triterpenes from edible mushroom Astraeus odoratus and their anti-Mycobacterium tuberculosis H37Ra and cytotoxic activity, J. Agric. Food Chem. 60 (2012) 9834-9841. https://doi.org/10.1021/jf302433r.

Crossref Google Scholar
[10]

M.J. Alves, I.C.F.R. Ferreira, I. Lourencßo, et al., Wild mushroom extracts potentiate the action of standard antibiotics against multiresistant bacteria, J. Appl. Microbiol. 116 (2014) 32-38. https://doi.org/10.1111/jam.12348.

Crossref Google Scholar
[11]

S.S. Chiang, L.T. Wang, S.Y. Chen, et al., Antibacterial and antiinflammatory activities of mycelia of a medicinal mushroom from Taiwan, Taiwanofungus salmoneus (higher Basidiomycetes), Int. J. Med. Mushrooms 15 (2013) 39-47. https://doi.org/10.1615/intjmedmushr.v15.i1.50.

Crossref Google Scholar
[12]

A.Y. Moussa, C. Lambert, T.E.B. Stradal, et al., New peptaibiotics and a cyclodepsipeptide from Ijuhya vitellina: isolation, identification, cytotoxic and nematicidal activities, Antibiotics (2020) 1-13. https://doi.org/10.3390/antibiotics9030132.

Crossref Google Scholar
[13]

O.E. Afieroho, X.S. Noundou, C.P. Onyia, et al., Antiplasmodial activity of the n-hexane extract from Pleurotus ostreatus (Jacq. ex. Fr) P. Kumm. Turkish, J. Pharm. Sci. 16 (2019) 37-42. https://doi.org/10.4274/tjps.18894.

Crossref Google Scholar
[14]

S.A., Ashraf, A.O., Elkhalifa, A.J., Siddiqui, et al., Cordycepin for health and wellbeing: a potent bioactive metabolite of an entomopathogenic medicinal fungus Cordyceps with its nutraceutical and therapeutic potential, Molecules 25 (2020). https://doi.org/10.3390/molecules25122735.

Crossref Google Scholar
[15]

H. Li, Y. Tian, N. Menolli Jr, et al., Reviewing the world's edible mushroom species: a new evidence-based classification system, Compr. Rev. Food Sci. F. 20 (2021) 1982-2014. https://doi.org/10.1111/1541-4337.12708.

Crossref Google Scholar
[16]

E.S.S. Tan, T.K. Leo, C.K. Tan, Effect of tiger milk mushroom (Lignosus rhinocerus) supplementation on respiratory health, immunity and antioxidant status: an open-label prospective study, Sci. Rep. 11 (2021) 1-10. https://doi.org/10.1038/s41598-021-91256-6.

Crossref Google Scholar
[17]

W.A. Elkhateeb, G.M. Daba, P.W. Thomas, et al., Medicinal mushrooms as a new source of natural therapeutic bioactive compounds, Egypt. Pharm. J. 18 (2019) 88-101. https://doi.org/10.4103/epj.epj_17_19.

Crossref Google Scholar
[18]
G.M. Halpern, Healing mushrooms, Mycologist (2017).
[19]

T. Fernandes, C. Garrine, J. Ferr, et al., Mushroom nutrition as preventative healthcare in Sub-Saharan Africa, Appl. Sci. 11(2021) 4221. https://doi.org/10.3390/app11094221.

Crossref Google Scholar
[20]

A.G. Niego, S. Rapior, N. Thongklang, et al., Macrofungi as a nutraceutical source: promising bioactive compounds and market value, J. Fungus 7 (2021). https://doi.org/10.3390/jof7050397.

Crossref Google Scholar
[21]

D.K. Patel, S.D. Dutta, K. Ganguly, et al., Mushroom-derived bioactive molecules as immunotherapeutic agents: a review, Molecules 26 (2021)1359. https://doi.org/10.3390/molecules26051359.

Crossref Google Scholar
[22]

N Roberto, Polyacetylenes from terrestrial plants and fungi: recent phytochemical and biological advances, Fitoterapia 106 (2015) 92-109. https://doi.org/10.1016/j.fitote.2015.08.011.

Crossref Google Scholar
[23]

W.J. Robbins, F. Kavanagh, A. Hervey, Antibiotics from Basidiomycetes: Ⅱ. Polyporus biformis, Proc. Natl. Acad. Sci. U.S.A. 33 (1947) 176-182. https://doi.org/10.1073/pnas.33.6.176.

Crossref Google Scholar
[24]

D.V. Kuklev, A.J. Domb, V.M. Dembitsky, Bioactive acetylenic metabolites, Phytomedicine 20 (2013) 1145-1159. https://doi.org/10.1016/j.phymed.2013.06.009.

Crossref Google Scholar
[25]

F. Kavanagh, A. Hervey, W.J. Robbins, Antibiotic substances from Basidiomycetes: V. Poria Corticola, Poria Tenuis and an unidentified Basidiomycete, Proc. Natl. Acad. Sci. U.S.A. 36 (1950) 1-7. https://doi.org/10.1073/pnas.36.1.1.

Crossref Google Scholar
[26]

M. Stadler, D. Hoffmeister, Fungal natural products: the mushroom perspective, Front. Microbiol. (2015). https://doi.org/10.3389/fmicb.2015.00127

Crossref Google Scholar
[27]

W.J. Robbins, F. Kavanagh, A. Hervey, Antibiotic substances from Basidiomycetes: Ⅰ. Pleurotus griseus, Proc. Natl. Acad. Sci. U.S.A. 33 (1947)171-176. https://doi.org/10.1073/pnas.33.6.171.

Crossref Google Scholar
[28]

S.M. Shipley, A.L. Barr, S.J. Graf, et al., Development of a process for the production of the anticancer lead compound pleurotin by fermentation of Hohenbuehelia atrocaerulea, J. Ind. Microbiol. Biotechnol. (2006) 463-468. https://doi.org/10.1007/s10295-006-0089-0.

Crossref Google Scholar
[29]

T. Degenkolb, A. Vilcinskas, Metabolites from nematophagous fungi and nematicidal natural products from fungi as alternatives for biological control. Part Ⅱ: metabolites from nematophagous basidiomycetes and nonnematophagous fungi, Appl. Microbiol. Biotechnol. 100 (2016) 3813-3824. https://doi.org/10.1007/s00253-015-7234-5.

Crossref Google Scholar
[30]

D. Chatterjee, D. Halder, U. Chakraborty, et al., Antimycobacterial activities of an edible mushroom extract and its synergy with the standard antituberculous drugs, J. Clin. Diagnostic Res. 12 (2018) DC37-DC41. https://doi.org/10.7860/JCDR/2018/35569.11640.

Crossref Google Scholar
[31]

D.K. Rahi, D. Malik, Diversity of mushrooms and their metabolites of nutraceutical and therapeutic significance, J. Mycology (2016) 1-18. https://doi.org/10.1155/2016/7654123

Crossref Google Scholar
[32]

S.K. Deshmukh, S.A. Verekar, B.N. Ganguli, Antimycobacterials from fungi, Fungi (2018) 41-69. https://doi.org/10.1201/b19958-6.

Crossref Google Scholar
[33]

R. Stanikunaite, M.M. Radwan, J.M. Trappe, et al., Lanostane-type triterpenes from the mushroom Astraeus pteridis with antituberculosis activity, J. Nat. Prod. 71 (2008) 2077-2079. https://doi.org/10.1021/np800577p.

Crossref Google Scholar
[34]

K. Rugutt, J. Rugutt, Relationships between molecular properties and antimycobacterial activities of steroids, Nat. Prod. Rep. 16 (2002) 107-113. https://doi.org/10.1080/10575630290020000.

Crossref Google Scholar
[35]

N. Sato, Q. Zhang, M. Hattori, Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense, Chem. Pharm. Bull. 57 (2009) 1076-1080.

Crossref Google Scholar
[36]

Q. Zhang, F. Zuo, N. Nakamoura, et al., Metabolism and pharmacokinetics in rats of ganoderiol F, a highly cytotoxic and antitumor triterpene from Ganoderma lucidum, J. Nat. Med. (2009) 304-310. https://doi.org/10.1007/s11418-009-0337-5.

Crossref Google Scholar
[37]

M. Isaka, P. Chinthanom, M. Sappan, et al., Antitubercular activity of mycelium-associated Ganoderma lanostanoids, J. Nat. Prod. 80 (2017) 1361-1369. https://doi.org/10.1021/acs.jnatprod.6b00973.

Crossref Google Scholar
[38]

L. Lin, M. Shiao, Seven new triterpenes from Ganoderma lucidum, Society 51 (1988) 918-924.

Crossref Google Scholar
[39]

M.S. Shiao, L.J. Lin, S.F. Yeh, et al., Two new triterpenes of the fungus Ganoderma lucidum, J. Nat. Prod. 50 (1987) 886-890. https://doi.org/10.1021/np50053a019.

Crossref Google Scholar
[40]

M.S. Shiao, L.J. Lin, S.F. Yeh, Triterpenes in Ganoderma lucidum, Phytochemistry 27 (1988) 2911-2914.

Crossref Google Scholar
[41]

M. Hirotani, C. Ino, T. Furuya, et al., Ganoderic acids T, S and R, new triterpenes from the cultured mycelia of Ganoderma lucidum, Chem. Pharm. Bull. 34 (1986) 430-433.

Crossref Google Scholar
[42]

C.H. Li, P.Y. Chena, U.M. Chang, et al., Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells, Life Sci. 77 (2005) 252-265. https://doi.org/10.1016/j.lfs.2004.09.045.

Crossref Google Scholar
[43]

M. Isaka, P. Chinthanom, M. Sappan, et al., Antitubercular lanostane triterpenes from cultures of the Basidiomycete Ganoderma sp. BCC 16642, J. Nat. Prod. 79 (2016) 161-169. https://doi.org/10.1021/acs.jnatprod.5b00826.

Crossref Google Scholar
[44]

M. Isaka, P. Chinthanom, S. Kongthong, et al., Lanostane triterpenes from cultures of the Basidiomycete Ganoderma orbiforme BCC 22324, Phytochemistry 87 (2013) 133-139. https://doi.org/10.1016/j.phytochem.2012.11.022..

Crossref Google Scholar
[45]

L. Shi, A. Ren, D. Mu, et al., Current progress in the study on biosynthesis and regulation of ganoderic acids, Appl. Microbiol. Biotechnol. 88 (2010)1243-1251. https://doi.org/10.1007/s00253-010-2871-1.

Crossref Google Scholar
[46]

J.W. Xu, W. Zhao, J.J. Zhong, Biotechnological production and application of ganoderic acids, Appl. Microbiol. Biotechnol. 87 (2010) 457-466. https://doi.org/10.1007/s00253-010-2576-5.

Crossref Google Scholar
[47]

R.R.M. Paterson, Ganoderma A therapeutic fungal biofactory, Phytochemistry 67 (2006) 1985-2001. https://doi.org/10.1016/j.phytochem.2006.07.004.

Crossref Google Scholar
[48]

H.P. Chen, Z.Z. Zhao, Z.H. Li, et al., Anti-proliferative and antiinflammatory lanostane triterpenoids from the polish edible mushroom Macrolepiota procera, J. Agric. Food Chem. 66 (2018) 3146-3154. https://doi.org/10.1021/acs.jafc.8b00287.

Crossref Google Scholar
[49]

S. Hettwer, S. Bänziger, B. Suter, et al., Grifolin derivatives from Albatrellus ovinus as TRPV1 receptor blockers for cosmetic applications, Int. J. Cosmet. Sci. 39 (2017) 379-385. https://doi.org/10.1111/ics.12385.

Crossref Google Scholar
[50]

Y. Hirata, K. Nakanishi, Grifolin, an antibiotic from a basidiomycete, J. Biol. Chem. 184 (1950) 135-143. https://doi.org/10.1016/s0021-9258(19)51132-2.

Crossref Google Scholar
[51]

T. Akihisa, S.G. Franzblau, H. Tokuda, et al., Antitubercular activity and inhibitory effect on Epstein-Barr virus activation of sterols and polyisoprenepolyols from an edible mushroom, Hypsizigus marmoreus, Chem. Pharm. Bull. 28 (2005) 1117-1119. https://doi.org/10.1248/bpb.28.1117.

Crossref Google Scholar
[52]

R.M. Centko, S. Ramón-García, T. Taylor, et al., Ramariolides A-D, antimycobacterial butenolides isolated from the mushroom Ramaria cystidiophora, J. Nat. Prod. 75 (2012) 2178-2182. https://doi.org/10.1021/np3006277.

Crossref Google Scholar
[53]

C.H. Hwang, B.U. Jaki, L.L. Klein, et al., Chlorinated coumarins from the polypore mushroom, Fomitopsis officinalis, and their activity against Mycobacterium tuberculosis, J. Nat. Prod. 23 (2006) 1-7. https://doi.org/10.1021/np400497f.

Crossref Google Scholar
[54]

N. Markova, V. Kussovskia, I. Drandarska, et al., Protective activity of Lentinan in experimental tuberculosis, Int. Immunopharmacol. 3 (2003)1557-1562. https://doi.org/10.1016/S1567-5769(03)00178-4.

Crossref Google Scholar
[55]

P.S. Bisen, R.K. Baghel, B.S. Sanodiya, et al., Lentinus edodes: a macrofungus with phammacological activities, Curr. Med. Chem. 17 (2010)2419-2430. https://doi.org/10.2174/092986710791698495.

Crossref Google Scholar
[56]

N. Lofgren, B.H.H. Luning, The isolation of nebularine and the determination of its structure, Acta Chem. Scand. 8 (1954) 670-680.

Crossref Google Scholar
[57]

B.S. Yun, IK. Lee, Y. Cho, et al., New tricyclic sesquiterpenes from the fermentation broth of Stereum hirsutum, J. Nat. Prod. 65 (2002) 786-788. https://doi.org/10.1021/np010602b.

Crossref Google Scholar
[58]

R. Sun, X. Zheng, X. Wang, et al., Two new benzofuran derivatives from the fungus Stereum sp. YMF1.1684, Phytochem. Lett. 4 (2011) 320-322. https://doi.org/10.1016/j.phytol.2011.06.003.

Crossref Google Scholar
[59]

M. Isaka, U. Srisanoh, W. Choowong, et al., Sterostreins A-E, new terpenoids from cultures of the basidiomycete Stereum ostrea BCC 22955, Org. Lett. 13 (2011) 4886-4889. https://doi.org/10.1021/ol2019778.

Crossref Google Scholar
[60]

O. Ogbole, P. Segun, T. Akinleye, et al., Antiprotozoal, antiviral and cytotoxic properties of the Nigerian mushroom, Hypoxylon fuscum pers. Fr. (Xylariaceae), Acta Chem. Scand. 56 (2018) 43-56. https://doi.org/10.23893/1307-2080.APS.05625.

Crossref Google Scholar
[61]

B.A. Quadros Gomes, L.F.D. da Silva, A.R. Quadros Gomes, et al., N-acetyl cysteine and mushroom Agaricus sylvaticus supplementation decreased parasitaemia and pulmonary oxidative stress in a mice model of malaria, Malaria J. 14 (2015) 1-12. https://doi.org/10.1186/s12936-015-0717-0.

Crossref Google Scholar
[62]

A.H.U. Cachóna, M.G. Angulob, R.B. Argáezb, et al., Antitubercular activity of the fungus Gliocladium sp. MR41 strain, Iran. J. Pharm. Res. 18 (2019)860-866. https://doi.org/10.22037/ijpr.2019.1100667.

Crossref Google Scholar
[63]

J.V. Orsine, L. Marques Brito, R.C. Silva, Cytotoxicity of Agaricus sylvaticus in non-tumor cells (NIH/3T3) and tumor (OSCC-3)using tetrazolium (MTT) assay, Nutr. Hosp. 28 (2013) 1244-1254. https://doi.org/10.3305/nh.2013.28.4.6461.

Crossref Google Scholar
[64]

S. Samchai, P. Seephonkai, A., Sangdee, et al., Antioxidant, cytotoxic and antimalarial activities from crude extracts of mushroom Phellinus linteus, J. Biol. Sci. 9 (2009) 778-783. https://doi.org/10.3923/jbs.2009.778.783.

Crossref Google Scholar
[65]

O.M. Oluba, A.O. Olusola, B.S. Fagbohunka, et al., Antimalarial and hepatoprotective effects of crude ethanolic extract of Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (W. Curt. Fr) P. Karst (higher Basidiomycetes), in Plasmodium berghei infected mice, Int. J. Med. Mushrooms 14 (2012) 459-466.

Crossref Google Scholar
[66]

W. Milliken, Malaria and antimalarial plants in Roraima, Brazil, Trop. Doct. 27 (1997) 20-25. https://doi.org/10.1177/00494755970270S108.

Crossref Google Scholar
[67]

J.D. Phillipson, C.W. Wright, Antiprotozoal agents from plant sources, Planta Med. 57 (1991) 53-59. https://doi.org/10.1055/s-2006-960230.

Crossref Google Scholar
[68]

K. Ma, J. Ren, J. Han, et al., Ganoboninketals A-C, antiplasmodial 3, 4-seco-27-norlanostane triterpenes from Ganoderma boninense Pat, J. Nat. Prod. 26(2014) 3-8. https://doi.org/10.1021/np5002863.

Crossref Google Scholar
[69]

K. Ma, L. Li, L. Bao, et al., Six new 3, 4-seco-27-norlanostane triterpenes from the medicinal mushroom Ganoderma boninense and their antiplasmodial activity and agonistic activity to LXRβ, Tetrahedron 71 (2015)1808-1814. https://doi.org/10.1016/j.tet.2015.02.002.

Crossref Google Scholar
[70]

M. Isaka, M. Sappan, W. Choowong, et al., Antimalarial lanostane triterpenoids from cultivated fruiting bodies of the Basidiomycete Ganoderma sp., J. Antibiot. 73 (2020) 702-710. https://doi.org/10.1038/s41429-020-0357-7.

Crossref Google Scholar
[71]

W. Lakornwong, K. Kanokmedhakul, S. Kanokmedhakul, et al., Triterpene lactones from cultures of Ganoderma sp. KM01, J. Nat. Prod. 77 (2014)1545-1553. https://doi.org/10.1021/np400846k.

Crossref Google Scholar
[72]

M. Isaka, A. Yangchum, S. Wongkanoun, et al., Marasmane and normarasumane sesquiterpenenoids from the edible mushroom Russula nigricans, Phytochem. Lett. 21 (2017) 174-178. https://doi.org/10.1016/j.phytol.2017.06.013.

Crossref Google Scholar
[73]

W.M. Daniewski, M. Gumulka, K. Ptaszynska, et al., Marmasane lactones from Lactarius vellereus, Phytochemistry 31 (1992) 913-915.

Crossref Google Scholar
[74]

M. Isaka, S. Palasarn, S. Sommaia, et al., Lanostane triterpenoids from the edible mushroom Astraeus asiaticus, Tetrahedron 73 (2017) 1561-1567. https://doi.org/10.1016/j.tet.2017.01.070.

Crossref Google Scholar
[75]

M. Adams, M. Christen, I. Plitzko, et al., Antiplasmodial lanostanes from the Ganoderma lucidum mushroom, J. Nat. Prod. 73 (2010) 897-900. https://doi.org/10.1021/np100031c.

Crossref Google Scholar
[76]

A.E. Wahba, A.K.A. El-Sayed, A.A. El-Falal, et al., New antimalarial lanostane triterpenes from a new isolate of Egyptian Ganoderma species, Med. Chem. Res. 28 (2019) 2246-2251. https://doi.org/10.1007/s00044-019-02450-1.

Crossref Google Scholar
[77]

M. Isaka, P. Chinthanom, K. Srichomthong, et al., Lanostane triterpenoids from fruiting bodies of the bracket fungus Fomitopsis feei, Tetrahedron Lett. 58 (2017) 1758-1761. https://doi.org/10.1016/j.tetlet.2017.03.066.

Crossref Google Scholar
[78]

C.T. Tokuyama, M. Nishxzawa, M. Shiro, et al., Malonate half-esters of homolanostanoid Ganoderma fungus from an Asian, Phytochemistry 29(1990) 923-928.

Crossref Google Scholar
[79]

J. RoÈsecke, W.A. KoÈnig, Constituents of the fungi Daedalea quercina and Daedaleopsis confragosa var. tricolor, Phytochemistry 54 (2000) 757-762.

Crossref Google Scholar
[80]

M.E. Duru, G.T. Çayan, Biologically active terpenoids from mushroom origin: a review, Rec. Nat. Prod. 9 (2015) 456-483.

Google Scholar
[81]

C. Intaraudom, N. Boonyuen, S. Supothina, et al., Novel spiro-sesquiterpene from the mushroom Anthracophyllum sp. BCC18695, Phytochem. Lett. 6(2013) 345-349. https://doi.org/10.1016/j.phytol.2013.04.006.

Crossref Google Scholar
[82]

S. Kanokmedhakul, R. Lekphroma, K. Kanokmedhakul, et al., Cytotoxic sesquiterpenes from luminescent mushroom Neonothopanus nambi, Tetrahedron 68 (2012) 8261-8266. https://doi.org/10.1016/j.tet.2012.07.057.

Crossref Google Scholar
[83]

N. Bunbamrung, C. Intaraudom, A. Dramae, et al., Antimicrobial activity of illudalane and alliacane sesquiterpenes from the mushroom Gloeostereum incarnatum BCC41461, Phytochem. Lett. 20 (2017) 274-281.https://doi.org/ 10.1016/j.phytol.2017.05.017.

Crossref Google Scholar
[84]

J. O'Brien, I. Wilson, T. Orton, et al., Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity, Eur. J. Biochem. 267 (2000) 5421-5426.https://doi.org/10.1046/j.1432-1327.2000.01606.x.

Crossref Google Scholar
[85]

K. Sadorn, S. Saepua, N. Boonyuen, et al., Antimicrobial activity and cytotoxicity of polyketides isolated from the mushroom: Xerula sp. BCC56836, RSC Adv. 6 (2016) 94510-94523. https://doi.org/10.1039/c6ra21898a.

Crossref Google Scholar
[86]

M. Isaka, S. Palasarn, M. Sappan, et al., Hirsutane sesquiterpenes from cultures of the Basidiomycete Marasmiellus sp. BCC 22389, Natur. Prod.Bioprosp. 6 (2016) 257-260. https://doi.org/10.1007/s13659-016-0105-7.

Crossref Google Scholar
[87]

S.E. Helaly, C. Richter, B. Thongbai, et al., Lentinulactam, a hirsutane sesquiterpene with an unprecedented lactam modification, Tetrahedron Lett.57 (2016) 5911-5913. https://doi.org/10.1016/j.tetlet.2016.11.075.

Crossref Google Scholar
[88]

J. Kornsakulkarn, C. Thongpanchang, R. Chainoy, et al., Bioactive metabolites from cultures of basidiomycete Favolaschia tonkinensis, J. Nat.Prod. 73 (2010) 759-762. https://doi.org/10.1021/np900777r.

Crossref Google Scholar
[89]

H. Balba, . Review of strobilurin fungicide chemicals, J. Environ. Sci. Health B 42 (2007) 441-451. https://doi.org/10.1080/03601230701316465.

Crossref Google Scholar
[90]

N. Tajuddeen, F.R. Van Heerden, Antiplasmodial natural products: an update, Malaria J. 18 (2019) 1-62. https://doi.org/10.1186/s12936-019-3026-1.

Crossref Google Scholar
[91]

J. Kornsakulkarn, S. Palasarn, W. Choowong, et al., Antimalarial 9-methoxystrobilurins, oudemansins, and related polyketides from cultures of Basidiomycete Favolaschia species, J. Nat. Prod. 83 (2020) 905-917.https://doi.org/10.1021/acs.jnatprod.9b00647.

Crossref Google Scholar
[92]

G. Ma, W. Yang, L. Zhao, et al., A critical review on the health promoting effects of mushrooms nutraceuticals. Food Sci. Human Wellness 7 (2018).https://doi.org/10.1016/j.fshw.2018.05.002.

Crossref Google Scholar
Food Science and Human Wellness
Volume 12 Issue 4,
July 2023
Pages 942-958
DOI: 10.1016/j.fshw.2022.10.017
Cite this article:
Moussa AY, Xu B. A narrative review on inhibitory effects of edible mushrooms against malaria and tuberculosis-the world's deadliest diseases. Food Science and Human Wellness, 2023, 12(4): 942-958. https://doi.org/10.1016/j.fshw.2022.10.017
Metrics & Citations  
Article History
Copyright
Rights and Permissions
Return